Here's a roundup of the latest coronavirus-related news.
Gabrielle Ientile, Assistant Editor
“Pharmacists are the safety net for their communities…we must ensure that these pharmacies have access to the tools they need to fight this pandemic and continue being there for patients in the future.”
In 2 prior clinical studies, gimsilumab demonstrated favorable results in treating the novel coronavirus.
The American Heart Association’s scientific statement outlines medications, procedures, and lifestyle change recommendations for individuals with both type2 diabetes and coronary artery disease.
GlaxoSmithKline and Sanofi have prioritized public health over competition in their agreement, announced today.
Neurofibromatosis type 1 (NF1) is a debilitating, progressive and often disfiguring disease that usually starts early in life.
V-Go® may provide a more affordable option for insulin therapy.
The letter asks the vice president to increase manufacturing of these medications based on current projections of critical care patient volume.
The findings highlight the importance of continuing to follow strict preventative measures, the CDC report said.
The successful maiden flight of an autonomous drone delivering insulin shows the potential for drone use in the delivery of lifesaving medications and supplies during disasters.